These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 30450981)

  • 1. Synergistic co-delivery of doxorubicin and melittin using functionalized magnetic nanoparticles for cancer treatment: loading and in vitro release study by LC-MS/MS.
    Hematyar M; Soleimani M; Es-Haghi A; Rezaei Mokarram A
    Artif Cells Nanomed Biotechnol; 2018; 46(sup3):S1226-S1235. PubMed ID: 30450981
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Magnetic targeted drug delivery carriers encapsulated with pH-sensitive polymer: synthesis, characterization and in vitro doxorubicin release studies.
    Wu J; Shen Y; Jiang W; Jiang W; Shen Y
    J Biomater Sci Polym Ed; 2016 Sep; 27(13):1303-16. PubMed ID: 27252073
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synthesis of Doxorubicin loaded magnetic chitosan nanoparticles for pH responsive targeted drug delivery.
    Unsoy G; Khodadust R; Yalcin S; Mutlu P; Gunduz U
    Eur J Pharm Sci; 2014 Oct; 62():243-50. PubMed ID: 24931189
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Thermal and pH responsive polymer-tethered multifunctional magnetic nanoparticles for targeted delivery of anticancer drug.
    Sahoo B; Devi KS; Banerjee R; Maiti TK; Pramanik P; Dhara D
    ACS Appl Mater Interfaces; 2013 May; 5(9):3884-93. PubMed ID: 23551195
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Magnetic hyperthermia and pH-responsive effective drug delivery to the sub-cellular level of human breast cancer cells by modified CoFe
    Oh Y; Moorthy MS; Manivasagan P; Bharathiraja S; Oh J
    Biochimie; 2017 Feb; 133():7-19. PubMed ID: 27916642
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Robust, active tumor-targeting and fast bioresponsive anticancer nanotherapeutics based on natural endogenous materials.
    Sun B; Deng C; Meng F; Zhang J; Zhong Z
    Acta Biomater; 2016 Nov; 45():223-233. PubMed ID: 27576338
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of Chemical Binding of Doxorubicin Hydrochloride to Gold Nanoparticles, Versus Electrostatic Adsorption, on the In Vitro Drug Release and Cytotoxicity to Breast Cancer Cells.
    Zayed GM; Kamal I; Abdelhafez WA; M Alsharif F; Amin MA; Shaykoon MSA; Sarhan HA; Abdelsalam AM
    Pharm Res; 2018 Mar; 35(6):112. PubMed ID: 29603025
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Synthesis and in vitro and in vivo evaluations of poly(ethylene glycol)-block-poly(4-vinylbenzylphosphonate) magnetic nanoparticles containing doxorubicin as a potential targeted drug delivery system.
    Hałupka-Bryl M; Asai K; Thangavel S; Bednarowicz M; Krzyminiewski R; Nagasaki Y
    Colloids Surf B Biointerfaces; 2014 Jun; 118():140-7. PubMed ID: 24769390
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Synergistic breast tumor cell killing achieved by intracellular co-delivery of doxorubicin and disulfiram via core-shell-corona nanoparticles.
    Tao X; Gou J; Zhang Q; Tan X; Ren T; Yao Q; Tian B; Kou L; Zhang L; Tang X
    Biomater Sci; 2018 Jun; 6(7):1869-1881. PubMed ID: 29808221
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A perfect stimuli-responsive magnetic nanocomposite for intracellular delivery of doxorubicin.
    Ghamkhari A; Ghorbani M; Aghbolaghi S
    Artif Cells Nanomed Biotechnol; 2018; 46(sup3):S911-S921. PubMed ID: 30307331
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Chitosan Immobilization on Bio-MOF Nanostructures: A Biocompatible pH-Responsive Nanocarrier for Doxorubicin Release on MCF-7 Cell Lines of Human Breast Cancer.
    Abazari R; Mahjoub AR; Ataei F; Morsali A; Carpenter-Warren CL; Mehdizadeh K; Slawin AMZ
    Inorg Chem; 2018 Nov; 57(21):13364-13379. PubMed ID: 30351060
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Enhanced doxorubicin delivery and cytotoxicity in multidrug resistant cancer cells using multifunctional magnetic nanoparticles.
    Pilapong C; Keereeta Y; Munkhetkorn S; Thongtem S; Thongtem T
    Colloids Surf B Biointerfaces; 2014 Jan; 113():249-53. PubMed ID: 24103503
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Preparation and characterization of magnetic gold nanoparticles to be used as doxorubicin nanocarriers.
    Elbialy NS; Fathy MM; Khalil WM
    Phys Med; 2014 Nov; 30(7):843-8. PubMed ID: 24950615
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficient delivery of anticancer drugs using functionalized-Ag-decorated Fe
    Romdoni Y; Prasedya ES; Kadja GTM; Kitamoto Y; Khalil M
    Biochim Biophys Acta Gen Subj; 2024 Aug; 1868(8):130643. PubMed ID: 38797254
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Folic acid-conjugated polyethylene glycol-coated magnetic nanoparticles for doxorubicin delivery in cancer chemotherapy: Preparation, characterization and cytotoxicity on HeLa cell line.
    Erdem M; Yalcin S; Gunduz U
    Hum Exp Toxicol; 2017 Aug; 36(8):833-845. PubMed ID: 27758842
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Co-delivery of erlotinib and doxorubicin by pH-sensitive charge conversion nanocarrier for synergistic therapy.
    He Y; Su Z; Xue L; Xu H; Zhang C
    J Control Release; 2016 May; 229():80-92. PubMed ID: 26945977
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Functionalized magnetic dextran-spermine nanocarriers for targeted delivery of doxorubicin to breast cancer cells.
    Tarvirdipour S; Vasheghani-Farahani E; Soleimani M; Bardania H
    Int J Pharm; 2016 Mar; 501(1-2):331-41. PubMed ID: 26875475
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Polyhydroxybutyrate-coated magnetic nanoparticles for doxorubicin delivery: cytotoxic effect against doxorubicin-resistant breast cancer cell line.
    Yalcin S; Unsoy G; Mutlu P; Khodadust R; Gunduz U
    Am J Ther; 2014; 21(6):453-61. PubMed ID: 25137407
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mesoporous γ-Iron Oxide Nanoparticles for Magnetically Triggered Release of Doxorubicin and Hyperthermia Treatment.
    Benyettou F; Ocadiz Flores JA; Ravaux F; Rezgui R; Jouiad M; Nehme SI; Parsapur RK; Olsen JC; Selvam P; Trabolsi A
    Chemistry; 2016 Nov; 22(47):17020-17028. PubMed ID: 27739116
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Glutamic acid-coated Fe
    Dutta B; Nema A; Shetake NG; Gupta J; Barick KC; Lawande MA; Pandey BN; Priyadarsini IK; Hassan PA
    Mater Sci Eng C Mater Biol Appl; 2020 Jul; 112():110915. PubMed ID: 32409067
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.